New potential for enhancing concomitant chemoradiotherapy with FDA approved concentrations of cisplatin via the photoelectric effect

We predict, for the first time, that by using United States Food and Drug Administration approved concentrations of cisplatin, major radiosensitization may be achieved via photoelectric mechanism during concomitant chemoradiotherapy (CCRT). Our analytical calculations estimate that radiotherapy (RT)...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Phys Med
Autors principals: Altundal, Yucel, Cifter, Gizem, Detappe, Alexandre, Sajo, Erno, Tsiamas, Panagiotis, Zygmanski, Piotr, Berbeco, Ross, Cormack, Robert A., Makrigiorgos, Mike, Ngwa, Wilfred
Format: Artigo
Idioma:Inglês
Publicat: 2014
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4492437/
https://ncbi.nlm.nih.gov/pubmed/25492359
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejmp.2014.11.004
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars